Skip to content

Cipher

Oculus Cipher

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202404916449600
Enrollment
2000
Registered
2024-04-19
Start date
2019-07-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Cipher

Sponsors

Grand Challenges Canada
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People with Severe Malaria or signs of severe malaria (e.g. loss of consciousness, convulsions, etc.) 2. Those residing within the community unit. 3. Those who consent to participate will be diagnosed.

Exclusion criteria

Exclusion criteria: Those unwilling to give consent will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the clinical trial established the effectiveness of the smartphone-based diagnostic device in accurately detecting and diagnosing cerebral malaria. Additionally, the trial evaluated the feasibility and acceptability of the system, particularly in African settings. This outcome determined the potential impact of the Cipher system on improving malaria diagnosis and healthcare delivery in resource-limited regions.

Secondary

MeasureTime frame
The evaluation of the diagnostic accuracy of the smartphone-based device compared to standard methods, assessing user satisfaction with the system, and examining its impact on healthcare delivery. These outcomes provide insights into the device's performance, usability, and potential benefits for both healthcare providers and patients.

Countries

Nigeria

Contacts

Public ContactEmmanuel Ugwu

MicroFuse Technologies

emmanuel.u@microfusetech.com+2347032398492

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026